TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 51 filers reported holding TALARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $16,121 | +71.6% | 8,575 | -6.9% | 0.00% | – |
Q4 2022 | $9,392 | -60.9% | 9,208 | +1.1% | 0.00% | – |
Q3 2022 | $24,000 | -44.2% | 9,104 | -5.1% | 0.00% | – |
Q2 2022 | $43,000 | -52.2% | 9,589 | +5.2% | 0.00% | – |
Q1 2022 | $90,000 | -49.4% | 9,112 | -21.8% | 0.00% | – |
Q4 2021 | $178,000 | +178.1% | 11,659 | +145.3% | 0.00% | – |
Q3 2021 | $64,000 | -64.6% | 4,752 | -61.4% | 0.00% | – |
Q2 2021 | $181,000 | – | 12,320 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 2,932,606 | $8,240,623 | 10.94% |
BML Capital Management, LLC | 2,000,000 | $5,620,000 | 5.16% |
Nantahala Capital Management | 2,953,129 | $8,298,292 | 0.71% |
GREAT POINT PARTNERS LLC | 1,000,000 | $2,810,000 | 0.51% |
Acuitas Investments, LLC | 194,547 | $546,677 | 0.32% |
Affinity Asset Advisors, LLC | 400,000 | $1,124,000 | 0.32% |
RA Capital Management | 2,403,238 | $6,753,099 | 0.13% |
Artal Group S.A. | 914,262 | $2,569 | 0.11% |
Blackstone Inc. | 8,089,315 | $22,730,975 | 0.10% |
QVT Financial LP | 589,314 | $1,655,972 | 0.09% |